Geode Capital Management
OSTX

Geode Capital Management’s OS Therapies Inc OSTX Stock Holding History

Geode Capital Management’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$395K Buy
280,045
+34,007
+14% +$48.3K ﹤0.01% 3683
2025
Q4 		$344K Buy
246,038
+58,350
+31% +$105K ﹤0.01% 3726
2025
Q3 		$368K Buy
+187,688
New +$372K ﹤0.01% 3724

Other funds holding OSTX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

Geode Capital Management's OSTX Position: Q1 2026 in Review

Geode Capital Management increased its OS Therapies Inc (OSTX) stake by 14% in Q1 2026, buying an estimated $48.3K and bringing the position to 280,045 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #3683.

Geode Capital Management first reported a position in OSTX in Q3 2025 and has held it in 3 quarters since. 29 funds tracked by Wall St. Rank hold OSTX as of Q1 2026.

  • Geode Capital Management held 280,045 shares of OS Therapies Inc worth $395K as of Q1 2026.
  • Geode Capital Management bought 34,007 OS Therapies Inc shares in Q1 2026, an estimated $48.3K.
  • OS Therapies Inc made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3683 holding.
  • Geode Capital Management first reported a position in OS Therapies Inc in Q3 2025 and has held it in 3 quarters since.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.